Institutional investors hold a majority ownership of ABBV through the 69.83% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2017, these large investors purchased a net $3.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 3.9 Million shares of AbbVie
ORBIS INVESTMENT MANAGEMENT LTD. Bought 3.9 Million shares of AbbVie
THE VANGUARD GROUP, INC. Bought 2.7 Million shares of AbbVie